Sivik Global Healthcare Has Decreased Its Biogen Com Stk (BIIB) Position; Ascena Retail Group (ASNA) Sentiment Is 1.18

April 20, 2018 - By Dolores Ford

Ascena Retail Group, Inc. (NASDAQ:ASNA) Logo

Ascena Retail Group Inc (ASNA) investors sentiment increased to 1.18 in Q4 2017. It’s up 0.02, from 1.16 in 2017Q3. The ratio improved, as 79 funds increased and opened new equity positions, while 67 cut down and sold positions in Ascena Retail Group Inc. The funds in our database now hold: 172.72 million shares, down from 178.41 million shares in 2017Q3. Also, the number of funds holding Ascena Retail Group Inc in top ten equity positions decreased from 4 to 3 for a decrease of 1. Sold All: 17 Reduced: 50 Increased: 47 New Position: 32.

Sivik Global Healthcare Llc decreased Biogen Inc Com Stk (BIIB) stake by 11.11% reported in 2017Q4 SEC filing. Sivik Global Healthcare Llc sold 2,500 shares as Biogen Inc Com Stk (BIIB)’s stock declined 17.01%. The Sivik Global Healthcare Llc holds 20,000 shares with $6.37M value, down from 22,500 last quarter. Biogen Inc Com Stk now has $55.86B valuation. The stock decreased 0.74% or $1.98 during the last trading session, reaching $264.04. About 562,671 shares traded. Biogen Inc. (NASDAQ:BIIB) has declined 3.66% since April 20, 2017 and is downtrending. It has underperformed by 15.21% the S&P500.

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on April, 24 before the open. They expect $5.95 earnings per share, up 14.42% or $0.75 from last year’s $5.2 per share. BIIB’s profit will be $1.26B for 11.09 P/E if the $5.95 EPS becomes a reality. After $5.26 actual earnings per share reported by Biogen Inc. for the previous quarter, Wall Street now forecasts 13.12% EPS growth.

Investors sentiment increased to 1.17 in 2017 Q4. Its up 0.04, from 1.13 in 2017Q3. It is positive, as 46 investors sold BIIB shares while 305 reduced holdings. 105 funds opened positions while 305 raised stakes. 180.65 million shares or 0.28% less from 181.16 million shares in 2017Q3 were reported. Dubuque Bankshares & Company invested in 239 shares. Tower Rech Limited Liability (Trc) reported 0.05% stake. Washington Trust Bancorporation has 2,531 shares for 0.12% of their portfolio. Osborne Prtn Cap Mngmt Limited Liability Company accumulated 1,664 shares. Hudock Cap Gp Ltd Liability reported 114 shares stake. 28,155 are owned by Auxier Asset Mngmt. Cornercap Inv Counsel Incorporated stated it has 0.95% in Biogen Inc. (NASDAQ:BIIB). Gmt Corporation invested in 319,100 shares. Moreover, Northcoast Asset Management Ltd Co has 0.07% invested in Biogen Inc. (NASDAQ:BIIB) for 2,290 shares. Comgest Glob Invsts Sas reported 18,000 shares. Shufro Rose & Co Llc reported 1,500 shares stake. Coldstream Mgmt Incorporated holds 0.03% or 987 shares in its portfolio. Wall Street Access Asset Ltd Llc has invested 1.01% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Moreover, Stoneridge Inv Ptnrs Ltd Liability Corporation has 2.64% invested in Biogen Inc. (NASDAQ:BIIB) for 51,777 shares. Monetary Management Gru Inc has invested 0.03% in Biogen Inc. (NASDAQ:BIIB).

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 23 have Buy rating, 0 Sell and 10 Hold. Therefore 70% are positive. Biogen Idec Inc. had 120 analyst reports since July 23, 2015 according to SRatingsIntel. The stock has “Hold” rating by Stifel Nicolaus on Tuesday, July 25. BMO Capital Markets maintained Biogen Inc. (NASDAQ:BIIB) rating on Friday, March 2. BMO Capital Markets has “Buy” rating and $393.0 target. The firm earned “Conviction Buy” rating on Wednesday, August 16 by Goldman Sachs. The stock has “Buy” rating by Goldman Sachs on Tuesday, October 24. The rating was upgraded by Goldman Sachs to “Buy” on Wednesday, July 26. The stock of Biogen Inc. (NASDAQ:BIIB) has “Strong-Buy” rating given on Tuesday, September 1 by Raymond James. Credit Suisse upgraded Biogen Inc. (NASDAQ:BIIB) rating on Wednesday, December 20. Credit Suisse has “Buy” rating and $385.0 target. The stock of Biogen Inc. (NASDAQ:BIIB) has “Overweight” rating given on Monday, November 7 by Piper Jaffray. The rating was maintained by Piper Jaffray on Thursday, January 18 with “Buy”. The firm has “Strong Buy” rating given on Thursday, December 29 by Raymond James.

Since January 9, 2018, it had 0 insider buys, and 5 sales for $2.87 million activity. Sandrock Alfred sold 743 shares worth $216,956. $1.92M worth of Biogen Inc. (NASDAQ:BIIB) was sold by PANGIA ROBERT W.

Sivik Global Healthcare Llc increased Neurocrine Biosciences Inc Com Stk (NASDAQ:NBIX) stake by 5,000 shares to 35,000 valued at $2.72 million in 2017Q4. It also upped Dr Reddy’s Laboratories Ltd Adr (NYSE:RDY) stake by 25,000 shares and now owns 75,000 shares. Zimmer Holdings Inc Com Stk (ZMH) was raised too.

The stock decreased 2.23% or $0.05 during the last trading session, reaching $2.19. About 316,848 shares traded. Ascena Retail Group, Inc. (ASNA) has declined 47.27% since April 20, 2017 and is downtrending. It has underperformed by 58.82% the S&P500.

Ratings analysis reveals 0 of Ascena Retail Group’s analysts are positive. Out of 4 Wall Street analysts rating Ascena Retail Group, 0 give it “Buy”, 0 “Sell” rating, while 4 recommend “Hold”. The lowest target is $7.0 while the high is $7.0. The stock’s average target of $7 is 219.63% above today’s ($2.19) share price. ASNA was included in 4 notes of analysts from September 20, 2016. On Thursday, December 15 the stock rating was initiated by Goldman Sachs with “Neutral”. RBC Capital Markets downgraded it to “Sector Perform” rating and $7.0 target in Tuesday, September 20 report. As per Tuesday, September 20, the company rating was maintained by Telsey Advisory. FBR Capital downgraded the stock to “Mkt Perform” rating in Tuesday, September 20 report.

Ascena Retail Group, Inc., through its subsidiaries, operates as a specialty retailer of apparel, shoes, and accessories for women and tween girls in the United States, Canada, and Puerto Rico. The company has market cap of $420.01 million. The firm operates through six divisions: ANN, Justice, Lane Bryant, maurices, dressbarn, and Catherines. It currently has negative earnings. It creates, designs, and develops a range of merchandise, including apparel, accessories, footwear, and intimates; lifestyle products comprising cosmetics and bedroom furnishings; and wear-to-work, sportswear, footwear, and social occasion apparel.

Golden Gate Private Equity Inc. holds 34.52% of its portfolio in Ascena Retail Group, Inc. for 17.47 million shares. Stadium Capital Management Llc owns 17.57 million shares or 22.4% of their US portfolio. Moreover, Icm Asset Management Inc Wa has 3.84% invested in the company for 1.52 million shares. The Missouri-based Towle & Co has invested 1.94% in the stock. Sterling Capital Management Llc, a North Carolina-based fund reported 4.85 million shares.

Analysts await Ascena Retail Group, Inc. (NASDAQ:ASNA) to report earnings on June, 14. They expect $-0.10 earnings per share, down 300.00% or $0.15 from last year’s $0.05 per share. After $-0.12 actual earnings per share reported by Ascena Retail Group, Inc. for the previous quarter, Wall Street now forecasts -16.67% EPS growth.

Ascena Retail Group, Inc. (NASDAQ:ASNA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>